Table 1 Extent of neoplastic progression in nine UC progressors

From: Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors

UC progressor patient

Most advanced neoplastic diagnosis

Dukes’ colorectal carcinoma stage

Incident neoplasia vs prevalent neoplasia vs unknown status

Extent of colonic disease

Age of UC onset (years)

UC disease duration (years)

PSC

P1

Carcinoma

Dukes’ B

Incident

Rectum

61

13

No

P2

High-grade dysplasia

Incident

Pancolitis

7

35

No

P3

Carcinoma

Dukes’ C

Prevalent

Pancolitis

20

13

No

P4

Carcinoma

Dukes’ B

Unknown

Pancolitis

5

35

No

P5

Carcinoma

Dukes’ A

Prevalent

Pancolitis

27

4

No

P6

High-grade dysplasia

Prevalent

Pancolitis

28

29

Yes

P7

Carcinoma

Dukes’ B

Incident

Pancolitis

?

Long Hx

No

P8

Carcinoma

Dukes’ A

Incident

Pancolitis

12

21

No

P9

Carcinoma

Dukes’ C

Unknown

Unknown

38

13

Yes

  1. Hx, history; ?, unknown; UC, ulcerative colitis; PSC, primary sclerosing cholangitis; incident neoplasia, diagnosed while under endoscopic biopsy surveillance; prevalent neoplasia, diagnosed at initial endoscopy.